Glycogen synthase kinase 3α and 3β have distinct functions during cardiogenesis of zebrafish embryo

BackgroundGlycogen synthase kinase 3 (GSK3) encodes a serine/threonine protein kinase, is known to play roles in many biological processes. Two closely related GSK3 isoforms encoded by distinct genes: GSK3α (51 kDa) and GSK3β (47 kDa). In previously studies, most GSK3 inhibitors are not only inhibiting GSK3, but are also affecting many other kinases. In addition, because of highly similarity in amino acid sequence between GSK3α and GSK3β, making it difficult to identify an inhibitor that can be selective against GSK3α or GSK3β. Thus, it is relatively difficult to address the functions of GSK3 isoforms during embryogenesis. At this study, we attempt to specifically inhibit either GSK3α or GSK3β and uncover the isoform-specific roles that GSK3 plays during cardiogenesis.ResultsWe blocked gsk3α and gsk3β translations by injection of morpholino antisense oligonucleotides (MO). Both gsk3α- and gsk3β-MO-injected embryos displayed similar morphological defects, with a thin, string-like shaped heart and pericardial edema at 72 hours post-fertilization. However, when detailed analysis of the gsk3α- and gsk3β-MO-induced heart defects, we found that the reduced number of cardiomyocytes in gsk3α morphants during the heart-ring stage was due to apoptosis. On the contrary, gsk3β morphants did not exhibit significant apoptosis in the cardiomyocytes, and the heart developed normally during the heart-ring stage. Later, however, the heart positioning was severely disrupted in gsk3β morphants. bmp4 expression in gsk3β morphants was up-regulated and disrupted the asymmetry pattern in the heart. The cardiac valve defects in gsk3β morphants were similar to those observed in axin1 and apcmcrmutants, suggesting that GSK3β might play a role in cardiac valve development through the Wnt/β-catenin pathway. Finally, the phenotypes of gsk3α mutant embryos cannot be rescued by gsk3β mRNA, and vice versa, demonstrating that GSK3α and GSK3β are not functionally redundant.ConclusionWe conclude that (1) GSK3α, but not GSK3β, is necessary in cardiomyocyte survival; (2) the GSK3β plays important roles in modulating the left-right asymmetry and affecting heart positioning; and (3) GSK3α and GSK3β play distinct roles during zebrafish cardiogenesis.

[1]  A. Ramsdell,et al.  Left-right asymmetry and congenital cardiac defects: getting to the heart of the matter in vertebrate left-right axis determination. , 2005, Developmental biology.

[2]  P. Cohen,et al.  The α‐isoform of glycogen synthase kinase‐3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase‐activated protein kinase‐1 in vitro , 1994, FEBS letters.

[3]  P. Pradat,et al.  The Epidemiology of Cardiovascular Defects, Part I: A Study Based on Data from Three Large Registries of Congenital Malformations , 2003, Pediatric Cardiology.

[4]  E. Olson,et al.  Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Didier Y. R. Stainier,et al.  Zebrafish genetics and vertebrate heart formation , 2001, Nature Reviews Genetics.

[6]  J. Woodgett,et al.  Glycogen synthase kinase-3: properties, functions, and regulation. , 2001, Chemical reviews.

[7]  Amie Y Lee,et al.  Inhibition of Wnt-1 Signaling Induces Apoptosis in β-Catenin-Deficient Mesothelioma Cells , 2004, Cancer Research.

[8]  Christina A. Wilson,et al.  GSK-3α regulates production of Alzheimer's disease amyloid-β peptides , 2003, Nature.

[9]  S. Mudaliar,et al.  Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. , 2000, Diabetes.

[10]  Andrej Shevchenko,et al.  Proteomics of early zebrafish embryos , 2006, BMC Developmental Biology.

[11]  J. Slingerland,et al.  Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression , 2003, Cell cycle.

[12]  C. Kimmel,et al.  Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[13]  J. Woodgett,et al.  Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy , 2000, The Journal of cell biology.

[14]  D. Green,et al.  GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. , 2004, Molecular cell.

[15]  Walter Birchmeier,et al.  Multiple roles of mesenchymal beta-catenin during murine limb patterning. , 2006, Development.

[16]  I. Dominguez,et al.  Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Jesús Avila,et al.  Glycogen synthase kinase 3: a drug target for CNS therapies , 2004, Journal of neurochemistry.

[18]  P. Pradat,et al.  The Epidemiology of Cardiovascular Defects, Part 2: A Study Based on Data from Three Large Registries of Congenital Malformations , 2003, Pediatric Cardiology.

[19]  M. Mercola,et al.  Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. , 2005, Genes & development.

[20]  Michel Goedert,et al.  GSK3 inhibitors: development and therapeutic potential , 2004, Nature Reviews Drug Discovery.

[21]  H. Eldar-Finkelman,et al.  Glycogen synthase kinase 3: an emerging therapeutic target. , 2002, Trends in molecular medicine.

[22]  R. Liao,et al.  Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart. , 2004, Journal of Biological Chemistry.

[23]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[24]  J. Markuns,et al.  Insulin and Exercise Decrease Glycogen Synthase Kinase-3 Activity by Different Mechanisms in Rat Skeletal Muscle* , 1999, The Journal of Biological Chemistry.

[25]  J. Schmitt,et al.  A Murine Model of Holt-Oram Syndrome Defines Roles of the T-Box Transcription Factor Tbx5 in Cardiogenesis and Disease , 2001, Cell.

[26]  E. Cuppen,et al.  The Wnt/beta-catenin pathway regulates cardiac valve formation. , 2003, Nature.

[27]  R. Jope,et al.  Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium , 2001, Brain Research.

[28]  K. Yutzey,et al.  Ventricular expression of tbx5 inhibits normal heart chamber development. , 2000, Developmental biology.

[29]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Zierler Maternal Drugs and Congenital Heart Disease , 1985, Obstetrics and gynecology.

[31]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[32]  G. E. Atilla‐Gokcumen,et al.  Organometallic Compounds with Biological Activity: A Very Selective and Highly Potent Cellular Inhibitor for Glycogen Synthase Kinase 3 , 2006, Chembiochem : a European journal of chemical biology.

[33]  Christina A. Wilson,et al.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. , 2003, Nature.

[34]  F. Hsieh,et al.  Germ‐line transmission of a myocardium‐specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  Andrew P McMahon,et al.  Ectodermal Wnt3/beta-catenin signaling is required for the establishment and maintenance of the apical ectodermal ridge. , 2003, Genes & development.

[36]  Chi‐Kuang Sun,et al.  Biomolecular imaging based on far-red fluorescent protein with a high two-photon excitation action cross section. , 2006, Optics letters.

[37]  M. Fishman,et al.  The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome. , 2002, Development.

[38]  Ana Martínez,et al.  Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation , 2002, Medicinal research reviews.

[39]  Walter Birchmeier,et al.  Multiple roles of mesenchymal β-catenin during murine limb patterning , 2006 .

[40]  R. Jope,et al.  Central Role of Glycogen Synthase Kinase-3β in Endoplasmic Reticulum Stress-induced Caspase-3 Activation* , 2002, The Journal of Biological Chemistry.

[41]  B. Stoica,et al.  Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3β, and induction of the mitochondrial-dependent intrinsic caspase pathway , 2003, Molecular and Cellular Neuroscience.

[42]  A. Zeiher,et al.  Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. , 2002, The Journal of clinical investigation.

[43]  J. Sadoshima,et al.  Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. , 2002, Circulation Research.

[44]  J. Woodgett,et al.  cDNA cloning and properties of glycogen synthase kinase-3. , 1991, Methods in enzymology.

[45]  R. Germack,et al.  Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes. , 2004, Journal of molecular and cellular cardiology.

[46]  S. Pierce,et al.  Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3. , 1995, Development.

[47]  P. Greengard,et al.  Pharmacological inhibitors of glycogen synthase kinase 3. , 2004, Trends in pharmacological sciences.

[48]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. , 2000, Nature.

[49]  C. Nüsslein-Volhard,et al.  Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish. , 1997, Development.

[50]  David I. Wilson,et al.  Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family , 1997, Nature Genetics.

[51]  J. Woodgett,et al.  Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. , 1992, The Journal of biological chemistry.

[52]  R. Knight,et al.  Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. , 2002, Journal of molecular and cellular cardiology.

[53]  T. Ogura,et al.  Tbx5 and Tbx4 trigger limb initiation through activation of the Wnt/Fgf signaling cascade , 2003, Development.

[54]  Wen-Chang Chang,et al.  Gene expression pattern Differential expression of glycogen synthase kinase 3 genes during zebrafish embryogenesis , 2000 .

[55]  James R. Woodgett,et al.  Judging a Protein by More Than Its Name: GSK-3 , 2001, Science's STKE.

[56]  A. Berns,et al.  Re-Evaluating the Role of Frat in Wnt-Signal Transduction , 2005, Cell cycle.

[57]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[58]  P. Cohen,et al.  Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. , 1993, The Biochemical journal.

[59]  D. Greenblatt,et al.  Lithium and the newborn heart. , 1990, Journal of clinical psychopharmacology.

[60]  E. Olson,et al.  Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. Chuang,et al.  Regulation and Function of Glycogen Synthase Kinase-3 Isoforms in Neuronal Survival* , 2006, Journal of Biological Chemistry.

[62]  L. Sommer Checkpoints of Melanocyte Stem Cell Development , 2005, Science's STKE.

[63]  Cheng-Yung Lin,et al.  Myogenic regulatory factors Myf5 and Myod function distinctly during craniofacial myogenesis of zebrafish. , 2006, Developmental biology.

[64]  Cheng-Yung Lin,et al.  Foxd3 mediates zebrafish myf5 expression during early somitogenesis. , 2006, Developmental biology.

[65]  J. Wojtaszewski,et al.  Regulation of glycogen synthase kinase-3 in human skeletal muscle: effects of food intake and bicycle exercise. , 2001, Diabetes.

[66]  J. Woodgett,et al.  Glycogen synthase kinase-3: functions in oncogenesis and development. , 1992, Biochimica et biophysica acta.

[67]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.